… MBC. Some breast cancers develop ESR1 mutations … breast cancer whose disease has recurred or progressed during or following an aromatase inhibitor … treatment in early breast cancer, including: NCT04975308 … of breast cancer diagnosed in 2024. Breast cancer …

… ESR1-mutated advanced or metastatic breast cancer (MBC) whose disease progressed … metastatic breast cancer whose disease recurred or progressed after aromatase inhibitor therapy … With ER+, HER2- Advanced Breast Cancer (EMBER-3). ClinicalTrials.gov. …

… precise cause of most breast cancers is unknown. Researchers … breast cancer include: Increasing age: The risk of breast cancer … breast cancer than men. A family history of breast cancer, … estrogen receptor modulators and aromatase inhibitors, may be used. …

… breast cancer will develop an ESR1 mutation after first-line treatment with aromatase inhibitor … to endocrine therapy with aromatase inhibitor exemestane or injectable SERD … welcomed by the Living Beyond Breast Cancer organisation for offering patients …

… patients with certain types of breast cancer. Inluriyo is indicated for adult … HER2-negative advanced or metastatic breast cancer, who also carry ESR1 mutations … progressed after treatment with an aromatase inhibitor. Participants were randomized to receive …

… –), ESR1-mutated advanced or metastatic breast cancer (MBC) whose disease progressed after … +, HER2–, ESR1-mutated MBC. Some breast cancers develop ESR1 mutations that can … MBC following recurrence on adjuvant aromatase inhibitor (AI), +/- prior CDK4 …

… -positive, HER2-negative advanced breast cancer that carries ESR1 gene mutations … patients with ESR1-mutated [metastatic breast cancer], a mutation found in … positive, HER2-negative breast cancer following progression on an aromatase inhibitor. While the …

… treatment of certain adults with breast cancer who experience disease progression … of certain adults with breast cancer who experience disease progression … or metastatic breast cancer who previously received treatment with an aromatase inhibitor alone …

… their cancer returned following adjuvant aromatase inhibitor (AI) therapy, with … , ESR1-mutated metastatic breast cancer. Some breast cancers develop ESR1 mutations that … breast cancer whose disease returned or progressed during or after aromatase inhibitor …

… mutated advanced or metastatic breast cancer (MBC) whose disease … therapy with an aromatase inhibitor with or without … ] expands the metastatic breast cancer treatment landscape for patients … ER+, HER2- Advanced Breast Cancer (EMBER-3). ClinicalTrials. …